Opinion

Ane Gerda Zahl Eriksson: SLN implementation for intermediate/high-risk Endometrial Cancer

Ane Gerda Zahl Eriksson and Pernille Bjerre Trent

Oct 25, 2024, 12:26

Ane Gerda Zahl Eriksson: SLN implementation for intermediate/high-risk Endometrial Cancer

Ane Gerda Zahl Eriksson, Head of the endometrial cancer and gynecologic sarcoma team at the Radium Hospital in Norway, shared a post by Pernille Bjerre Trent, Gynecologist at Oslo University Hospital and Phd-student at Universitety of Oslo (UiO), on LinkedIn, adding:

“Excited to see this collaboration between our department of Gynecological Oncology at Oslo Universitetssykehus and The Department of Health Management and Health Econimics at Universitetet i Oslo (UiO) published in International Journal of Gynecological Cancer (IJGC)

SLN implementation for intermediate/high-risk Endometrial Cancer is cost-effective with high health outcomes

So, essentially better QoL for our patients for less health-dollars spent.
It’s win-win!

Congratulations to Pernille Bjerre Trent on publication of the third paper as part of her PhD Thesis at Det medisinske fakultet UiO.

Thanks to collaborators Emily Burger and Knut Reidar Wangen at HELSAM.

Link to open access full article in original post.”

Quoting Pernille Bjerre Trent‘s post:

“Third article in my PhD is finally out.

Fresh from the press:
The implementation of SLN is cost-effective with lower costs and better health outcomes in patients with intermediate- and high-risk endometrial carcinoma.”

A cost-effectiveness analysis of sentinel lymph node biopsy compared with lymphadenectomy in intermediate- and high-risk endometrial carcinoma

Authors: Pernille Bjerre Trent, Ane Gerda Eriksson, Anne Cathrine Staff, Knut Erling Juul-Hansen, Emily Annika Burger, Knut Reidar Wangen

Ane Gerda Zahl Eriksson

Ane Gerda Z Eriksson is the head of the endometrial cancer and gynecologic sarcoma team at the Radium Hospital in Norway and an associate professor at the University of Oslo. She is an active member of several national and international societies, and is currently Chair of the surgical group in the Nordic Society of Gynecologic Oncology, Education Committee Vice Chair for the International Gynecologic Cancer Society, Vice Chair for the Norwegian Society of Gynecologic Oncology and social media editor for the International Journal of Gynecologic Cancer.